TO CURE A ROSE FOUNDATION (EIN 862919742) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

Judy Foppiano

Phone

5129404164

Tax Period

2024-01-01 to 2024-12-31

TO CURE A ROSE FOUNDATION, founded in 2021, is a small nonprofit in the Medical Research sector that reported $401K in total revenue in fiscal year 2024. Revenue decreased 18% compared to the prior year.

Mission

Mission is to facilitate bringing genetic therapies to children with HNRNPH2, and children with rare diseases as a whole.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $296,975

Program Service Revenue $0

Investment Income $0

Other Revenue $104,130

TOTAL REVENUE $401,105

Expense Breakdown

Grants Paid $0

Salaries & Benefits $140,637

Fundraising Expenses $0

Program Expenses $341,653

Other Expenses $285,918

TOTAL EXPENSES $426,555

Year-over-Year Comparison

	2024	2023	Change
Revenue	$401,105	$491,783	-0.2%
Expenses	$426,555	$392,902	+0.1%
Net Income	$-25,450	$98,881	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

100

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Lowell Simon	Chairman	5.00	Director	$0	$0	$0
Casey McPherson	Executive Dir.	40.00	Officer Director	$0	$0	$0
Judy Foppiano	Treasurer	2.00	Officer Director	$0	$0	$0
Patti Stoetzner	Director	2.00	Officer Director	$0	$0	$0
Julia Vitarello	Director	2.00	Director	$0	$0	$0
Bud Sartain	Director	1.00	Director	$0	$0	$0
Richard Finnell	Director	5.00	Director	$0	$0	$0
Shawn Dinwiddie	Trustee	2.00	Director	$0	$0	$0
Henry Weinert	Trustee	2.00	Director	$0	$0	$0
Huiping Zhu	Trustee	2.00	Director	$0	$0	$0
Peter Sleeper	Trustee	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$401,105	$426,555	$178,767	$-25,450
2023	$491,783	$392,902	$209,920	$98,881
2022	$323,040	$348,225	$104,718	$-25,185
2021	$214,982	$85,277	$129,705	$129,705

TO CURE A ROSE FOUNDATION